Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: C Wright who wrote (5974)	2/2/1998 3:46:00 PM
From: scaram(o)uche	Respond to of 9262

[ HYSQ ] Ray..... "may"? ;-) It's moving further.... Rick

To: C Wright who wrote (5974)	2/2/1998 4:07:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 9262

[ HYSQ ] Carol..... >>Why couldn't I have seen this coming at 9:00 !!<< Yeah, I was busy at school with my kids. That's O.K., volume indicates that few have digested it yet. One other comment... it will sink in that SKB is a great complement to AFFX/HGSI for combinatorial chemistry, but that, in general, such alliances will be weak in this area. ARQL has bounced back about 35%, but I expect it to slowly motor. Hope I'm correct. Do others have commentary about SKB/Glaxo and the AFFX/HGSI rationale? A friend, Jim Silverman, called it independently of the WSJ article. Rick